In recent trading session, Seres Therapeutics Inc (NASDAQ:MCRB) saw 0.75 million shares changing hands at last check today with its beta currently measuring 1.84. Company’s recent per share price level of $1.36 trading at $0.0 or 0.00% at last check today assigns it a market valuation of $205.97M. That most recent trading price of MCRB’s stock is at a discount of -288.97% from its 52-week high price of $5.29 and is indicating a premium of 60.29% from its 52-week low price of $0.54. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.21 million shares which gives us an average trading volume of 4.85 million if we extend that period to 3-months.
For Seres Therapeutics Inc (MCRB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Seres Therapeutics Inc (NASDAQ:MCRB) trade information
Wall Street analysts have assigned a consensus price target of 1.25 to the stock, which implies a fall of -8.8% to its recent value today. Analysts have been projecting 1.25 as a low price target for the stock while placing it at a high target of 1.25. It follows that stock’s current price would jump 8.09% in reaching the projected high whereas dropping to the targeted low would mean a gain of 8.09% for stock’s current value.
Seres Therapeutics Inc (MCRB) estimates and forecasts
Statistics highlight that Seres Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 20.35% of value to its shares in past 6 months, showing an annual growth rate of -15.73% while that of industry is 15.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.22% during past 5 years.
Seres Therapeutics Inc (NASDAQ:MCRB)’s Major holders
Insiders are in possession of 0.41% of company’s total shares while institution are holding 56.71 percent of that, with stock having share float percentage of 56.94%. Investors also watch the number of corporate investors in a company very closely, which is 56.71% institutions for Seres Therapeutics Inc that are currently holding shares of the company. FLAGSHIP PIONEERING INC. is the top institutional holder at MCRB for having 23.12 million shares of worth $17.89 million. And as of 2024-03-31, it was holding 18.0597 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 22.65 million shares on 2024-03-31. The number of shares represents firm’s hold over 17.696 of outstanding shares, having a total worth of $17.53 million.
